If you want to get an overview of the different parties involved in the new health system and their roles – including some new players as well as old players with new responsibilities – a recent report from the National Quality Board‘s (NQB) is worth a look.
WalesOnline reports on confirmation by the Welsh Government that it is to publish data on patients’ requests for funding for drugs, following FOI requests that revealed “large disparities in the number of requests for funding for cancer drugs not approved by the All-Wales Medicines Strategy Group (AWMSG) or the National Institute for Health and Clinical Excellence (Nice).
“Some health boards refused two-thirds of these funding requests, while others declined just 15%.”
The data is to be published on a health board basis, rather than at a national level. Continue reading →